Classifying antibiotics in the WHO essential medicines list for optimal use—be AWaRe
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Respondents dispensed not only Access group antibiotics but also Watch group antibiotics, which could lead to rapid development of AMR.
“Respondents dispensed not only Access group antibiotics but also Watch group antibiotics, which could also lead to the rapid development of AMR, as mentioned by the WHO [10].”
From Over-the-Counter Sale of Antibiotics in India: A Qualitative Study of Providers’ Perspectives across Two States (2021) · cites this paper as [10]
The citation lists haven’t been fetched yet
References 5 · Cited by 336
- Authors
- Sharland, M., Pulcini, C., Harbarth, S., Zeng, M., Gandra, S., Mathur, S., & Magrini, N.
- Affiliations
- St George's, University of London (GB)
- University of Geneva (CH)
- Children's Hospital of Fudan University (CN)
- Center for Disease Dynamics, Economics and Policy (IN)
- World Health Organization (CH)
- Corresponding author
- Magrini, Nicola
- ORCID
- Sharland, Mike
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 18
- Issue
- 1
- Pages
- 18-20
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2780214698
- Cited by
- 336
- References
- 5
- Citations by year
- 2026: 33 · 2025: 49 · 2024: 41 · 2023: 43 · 2022: 44 · 2021: 48 · 2020: 43 · 2019: 26 · 2018: 9
- FWCI
- 16.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- HAL (submittedVersion)
- Funders
- Innovative Medicines Initiative
- Pfizer UK
- GlaxoSmithKline
- Topics
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- antibiotics, WHO Model List of Essential Medicines, antibiotic classification, antimicrobial stewardship, antimicrobial resistance, antibiotic prescribing, low- and middle-income countries, Sustainable Development Goal 3
- MeSH terms
- Anti-Bacterial Agents, Bacterial Infections, Drug Utilization, Health Services Accessibility, Humans, World Health Organization, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
